dihexa safety concerns hgf c-met cancer risk Developing pathway inhibitors for therapy: progress and challenges: Trends in Molecular Medicine Correlation between hypoxia and HGF/c-MET
Correlation between hypoxia and HGF c MET expression in the management of pancreatic cancer ScienceDirect Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease Frontiers HGF and MET: From Brain Development to Neurological Disorders Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect dihexa cancer risk c met is an experimental cognitive peptide that may help the brain build Increased HGF Expression Induces Resistance to c MET Tyrosine Kinase Inhibitors in Gastric Cancer Anticancer Research
Pay in 4 interest-free payments of $5.67 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




